iXensor, the pioneer of mobile health, infuses its corporate DNA of digital savviness into its upcoming product launch in January 2021. The PixoTest® COVID-19 Antigen Test, together with the PixoTest® POCT Analyzer, can yield positive results objectively in as short as 5 minutes through computer-aided analysis, minimizing the chances of misinterpretation by…
PixoTest POCT System and PixoTech technology covered in Health & Care Management
iXensor attended Medica 2020 in October and presented the PixoTech technology as well as its new application of smart COVID-19 management. “Health & Care Management” from Germany reported it as “Pioneering medical technology from Taiwan.” Read the full article here: https://www.hcm-magazin.de/zukunftsweisende-medizintechnik-aus-taiwan/150/25761/408612
iXensor announces its residency at Johnson Innovation’s JLABS
iXensor announced today that, effective December 1st, it has become a resident of Johnson & Johnson Innovation – JLABS @ Shanghai. This is an important step toward further accelerating its PixoTech platform development and smartphone-based testing applications for new disease areas, leveraging JLABS’ global network and resources. Johnson Innovation…